Professor Hendrik Tobias Arkenau areas of expertise:
Professional statement
Professor Hendrik Tobias Arkenau is a prominent medical oncologist in London who specialises in the treatment of gastrointestinal cancer, stomach cancer, liver cancer, pancreatic cancer, bowel cancer and immunotherapies.
He was awarded his medical degree from Hanover Medical School in Germany in 2000. He then completed his specialist training in oncology across numerous centres of excellence, including the Royal Marsden Hospital. He was awarded a Fellowship by the Royal College of Physicians and he plays a crucial role in his field of gastrointestinal cancers, drug development and immunotherapy thanks to his research contributions.
Professor Arkenau is the founding Medical Director of the Sarah Cannon Research Institute UK and he is currently the Executive Medical Director for the institute. He is a chief and principal investigator of numerous clinical trials of new anti-cancer drugs, including immunotherapies and cellular therapies.
He is a professional research associate at the University College London Hospital. Throughout his career, he has published numerous peer-reviewed articles and book chapters and regularly contributes at international and national meetings.
Patient reviews
N B. Verified Patient
27/03/2024
Would you recommend this doctor?
Patients comments
Exceptional
S D. Verified Patient
17/01/2024
Would you recommend this doctor?
Patients comments
Professor Arkenau is a kind, thorough and very well-informed oncologist who really cares for his patients and their families. He treated my father and husband who are both alive and well today. I can't recommend him highly enough.
P R. Verified Patient
16/08/2023
Would you recommend this doctor?
Patients comments
Had very good experience of treatment by Toby , my gastric cancer is cured and he has the best contacts for surgeons etc.
M W. Verified Patient
23/06/2023
Would you recommend this doctor?
Patients comments
Professor Hendrik was extremely kind and personable. He informed us of the options available and explained what we should do next. He advised us on what to ask our NHS oncologist and explained the potential trial details.The appointment gave us hope and a plan in moving forward